^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

FCGRT (Fc Gamma Receptor And Transporter)

i
Other names: FCGRT, Fc Gamma Receptor And Transporter, Fc Fragment Of IgG Receptor And Transporter, Neonatal Fc Receptor, FCRN, Heavy Chain Of The Major Histocompatibility Complex Class I-Like Fc Receptor, Transmembrane Alpha Chain Of The Neonatal Receptor, Fc Fragment Of IgG Receptor Transporter Alpha, IgG Fc Fragment Receptor Transporter Alpha Chain, IgG Receptor FcRn Large Subunit P51, Alpha-Chain, FcRn, Major Histocompatibility Complex Class I-Like Fc Receptor, Immunoglobulin Receptor, Intestinal, Heavy Chain, Neonatal Fc-Receptor For Ig, FCRN Alpha-Chain, FcRn Alpha Chain, FcgammaRn
Associations
2ms
Genetic insights into colorectal cancer pathogenesis: a multi-omics and immunity perspective. (PubMed, Transl Cancer Res)
These genes were also found to be associated with tumor mutational burden (TMB) and microsatellite instability (MSI) scores. Our findings reveal how these genes contribute to CRC pathogenesis by modulating the immune microenvironment, providing important biomarkers and targets for the development of novel therapeutic strategies.
Journal • Tumor mutational burden • IO biomarker
|
TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • RIPK2 (Receptor Interacting Serine/Threonine Kinase 2) • FCGRT (Fc Gamma Receptor And Transporter) • S100P (S100 calcium binding protein P)
7ms
Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies. (PubMed, Sci Rep)
This model integrates hFcRn cDNA into the endogenous locus of the mouse Fcgrt gene, completely replacing native mouse FcRn (mFcRn) expression. The hiFcRn mouse model offers a more human-relevant platform for the preclinical evaluation of therapeutic antibodies and Fc-fusion proteins.
PK/PD data • Preclinical • Journal
|
FCGRT (Fc Gamma Receptor And Transporter)
1year
Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells. (PubMed, Int J Mol Sci)
In these lines, the main viral receptor genes, including PVR, CXADR, CD55, ITGA2, SCARB2, ICAM1, and FCGRT, were knocked out using the CRISPR/Cas9 system. The panel of lines was validated on twelve different Enteroviruses types, providing a basis for studying the molecular mechanisms of enterovirus entry into cells, and for developing new therapeutic strains.
Preclinical • Journal
|
ICAM1 (Intercellular adhesion molecule 1) • IFNAR1 (Interferon (alpha, beta and omega) receptor 1) • CD55 (CD55 Molecule) • CXADR (CXADR Ig-Like Cell Adhesion Molecule) • FCGRT (Fc Gamma Receptor And Transporter) • ITGA2 (Integrin Subunit Alpha 2)
over1year
Markers of Favorable Response to FcRn Inhibitors(INFORM) (clinicaltrials.gov)
P=N/A, N=50, Recruiting, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
New trial
|
FCGRT (Fc Gamma Receptor And Transporter)
over1year
New trial
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CEACAM5 (CEA Cell Adhesion Molecule 5) • LGALS1 (Galectin 1) • LGALS3 (Galectin 3) • IL17A (Interleukin 17A) • IL15 (Interleukin 15) • IL1B (Interleukin 1, beta) • CRP (C-reactive protein) • FCGRT (Fc Gamma Receptor And Transporter)
2years
Decoupling FcRn and Tumor Contributions to Elevated Immune Checkpoint Inhibitor Clearance in Cancer Cachexia. (PubMed, Pharmacol Res)
We also observed severe cachexia and decreased, instead of increased, baseline pembrolizumab clearance in the tumor-free cisplatin-induced cachexia model. We conclude cachexia phenotype coincides with altered antibody clearance, though tumor presence is neither sufficient nor necessary for elevated clearance in immunocompetent mice. Magnitude and direction of clearance alteration correlated with hepatic Fcgrt, suggesting changes in FcRn expression and/or recycling function may be partially responsible, though factors beyond FcRn also contribute to altered clearance in cachexia.
Journal • Checkpoint inhibition • PD(L)-1 Biomarker • IO biomarker
|
FCGRT (Fc Gamma Receptor And Transporter)
|
Keytruda (pembrolizumab) • cisplatin
2years
FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features. (PubMed, Diagnostics (Basel))
To the best of our knowledge, this study represents the initial assessment of FcRn expression in endometrioid EC samples. FcRn expression was significantly associated with the FIGO stage. Ishikawa cell line proliferation did not significantly change in response to decreased FcRn expression. Further studies are needed to elucidate FcRn expression in EC as a potential molecular parameter.
Journal
|
FCGRT (Fc Gamma Receptor And Transporter)
3years
2'-Fucosyllactose Inhibits Coxsackievirus Class A Type 9 Infection by Blocking Virus Attachment and Internalisation. (PubMed, Int J Mol Sci)
Molecular docking results revealed that 2'-FL interacted with the attachment receptor αβ and the internalisation receptor FCGRT and βM with an affinity of -2.14, -1.87, and -5.43 kcal/mol, respectively. This study lays the foundation for using 2'-FL as a food additive against CV-A9 infections.
Journal
|
FCGRT (Fc Gamma Receptor And Transporter)
over3years
Neutrophil-related genes predict prognosis and response to immune checkpoint inhibitors in bladder cancer. (PubMed, Front Pharmacol)
Taken together, a novel prognostic model was developed based on the expression level of neutrophil-related genes. FCGRT served as a promising candidate biomarker for anti-cancer drug response, which may contribute to individualized prognostic prediction and may contribute to clinical decision-making.
Journal • Checkpoint inhibition • Tumor Mutational Burden • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • TMB (Tumor Mutational Burden) • H2BC8 (H2B Clustered Histone 8) • FCGRT (Fc Gamma Receptor And Transporter) • MX1 (MX Dynamin Like GTPase 1)
|
PD-L1 expression